| Product Information |
|
| Registration Number |
BR-917
|
| Generic Name |
Measles, Mumps and Rubella Vaccine (Live,
Attenuated)
|
| Brand Name |
M-M-R II
|
| Dosage Strength |
REMARKS:
Formulation:
After reconstitution, each dose (0.5 mL) contains:
Live, attenuated virus derived from Edmonston B strain of measles………………… 3.0 log TCID50*
Live, attenuated Jeryl Lynn strain of mumps…………..4.1 log TCID50*
Live, attenuated Wistar RA27/3 strain of rubella. …………3.0 log TCID50*
*TCID 50 - Tissue Culture Infectivity Dose 50%
|
| Dosage Form |
Lyophilized Powder for Solution for Injection (IM/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Single dose. 3 mL Type I clear glass vial + 0.5 mL clear glass vial (Sterile Water for Injection as diluent) (Box of 1's and 10's).
|
| Pharmacologic Category |
-
|
| Manufacturer |
Merck Sharp and Dohme LLC
|
| Country of Origin |
U.S.A
|
| Trader |
N/A
|
| Importer |
Merck Sharp & Dohme (I.A.) LLC
|
| Distributor |
Merck Sharp & Dohme (I.A.) LLC
|
| Application Type |
Renewal
|
| Issuance Date |
26 April 2023
|
| Expiry Date |
26 January 2028
|